Entering text into the input field will update the search result below

Pieris Pharmaceuticals EPS beats by $0.10, beats on revenue

  • Pieris Pharmaceuticals (NASDAQ:PIRS): Q1 GAAP EPS of -$0.07 beats by $0.10.
  • Revenue of $15.63M (+17.9% Y/Y) beats by $9.93M.
  • Press Release

Recommended For You

More Trending News

About PIRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PIRS--
Pieris Pharmaceuticals, Inc.